BioNexus Gene Lab Corp. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $600.70K.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for the quarter ending 2022-06-30 was $150.00K.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $4.29M.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for fiscal 2023 was $1.05K, a 99.30% decline from fiscal 2022.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for fiscal 2022 was $150.00K.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for fiscal 2020 was $4.29M, a 14200.62% increase from fiscal 2019.
- BioNexus Gene Lab Corp. stock issued during period, value, new issues for fiscal 2019 was $30.03K.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-12-31 | $1.05K 10-K · filed 2024-04-16 | |
| 2023-09-30 | $600.70K 10-Q/A · filed 2024-03-26 | |
| 2022-12-31 | $150.00K 10-K · filed 2024-04-16 | |
| 2022-06-30 | $150.00K 10-Q/A · filed 2024-03-26 | |
| 2020-12-31 | $4.29M 10-K · filed 2022-04-06 | |
| 2020-03-31 | $4.29M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $30.03K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |